Flat chip uses twisted light to reveal hidden images and detect molecular chirality

The difference between a medicine and a poison often comes down to which way a molecule spirals.
Researchers explain why detecting molecular handedness matters for pharmaceutical safety and drug verification.
Mark

So the researchers encoded two images on one chip, but you can only see them under different light conditions. How does that actually work?

Mimi

They built the chip from tiny structures called meta-atoms. The size of each meta-atom encodes one image—that one shows up under normal unpolarized light. But the angle or orientation of those same meta-atoms encodes a second image that only appears when you shine circularly polarized light on it.

Luke

Right, but I want to be clear about what "only appears" means. The second image isn't invisible in some magical sense. It's that the metasurface is designed to absorb or reflect different amounts of the two types of circularly polarized light depending on the meta-atom orientation. You need the right detector and the right light source to read it.

Mimi

Exactly. It's not hidden by darkness or camouflage. It's hidden by the fact that you're not using the right tool to look at it.

Mark

And the practical use case is security—like a watermark that only shows up under specific conditions?

Mimi

Yes. Anticounterfeiting, authentication, camouflage. If you can embed information that's invisible to casual inspection but readable to someone with the right equipment, that's powerful for verifying authenticity.

Luke

Though I should note the paper demonstrates the concept with mid-infrared light, which is already invisible to the human eye. So the "invisible" part is partly because we can't see infrared anyway. The real innovation is the dual encoding on one surface.

Mark

What about the drug safety angle? That seems like the bigger story.

Mimi

Molecules have handedness too. A left-handed version of a drug might be medicine, while the right-handed version could be useless or toxic. These metasurfaces can detect which version you have by seeing how they interact with twisted light.

Luke

And that matters because?

Mimi

Because if you're manufacturing a drug, you need to know you're making the right-handed or left-handed version, not a mixture. A tiny sample on this chip could tell you instantly.

Mark

So this is about quality control in pharmaceutical manufacturing?

Mimi

That's one application. But more broadly, it's about being able to sense molecular chirality quickly and reliably from small samples. That opens doors in biosensing, drug purity verification, all kinds of diagnostics.

Luke

The paper doesn't describe an actual drug-testing experiment, though. That's a potential application they're pointing toward, not something they've demonstrated yet.

  • The stakes are ancient and urgent: a drug molecule with its handedness flipped can become inert or lethal, yet detecting that difference at scale has remained stubbornly difficult.
  • EPFL's Bionanophotonic Systems Laboratory has broken through by orchestrating the orientation of microscopic meta-atoms across a flat chip, allowing precise control over how twisted light interacts with chiral matter.
  • A striking proof-of-concept encoded two separate images on a single chip — a cockatoo visible under ordinary light, a mountain revealed only when circularly polarized light is applied — demonstrating invisible dual-layer watermarking.
  • The disruption ripples outward: anticounterfeiting, quantum computing, and pharmaceutical verification are all suddenly within reach of a technology no thicker than a wafer.
  • The trajectory points toward a world where drug purity can be confirmed from tiny samples before reaching patients, and where the shape of light and the shape of matter finally operate in shared fluency.

Light, like life, has a handedness — and for centuries, distinguishing the left-handed from the right-handed has been one of science's most consequential challenges. Researchers at EPFL have now engineered flat optical chips, called metasurfaces, that harness the twist of circularly polarized light to reveal hidden images and detect the molecular chirality that separates medicines from poisons. Published in Nature Communications, the work demonstrates that elegant arrangement — not brute complexity — can give humanity finer control over the invisible geometry that shapes DNA, drugs, and the boundaries of the possible.

A left-handed glove will never fit a right hand — and this principle of handedness, called chirality, governs far more than clothing. It shapes DNA, determines whether a sugar nourishes or passes through the body unused, and decides whether a pharmaceutical compound will heal or harm. Flip the handedness of a drug molecule, and it may become inert or toxic. Detecting and controlling chirality has long been a frontier of molecular science.

Light itself can be handed. Circularly polarized light twists through space like a corkscrew — either left or right — and chiral molecules interact differently with each twist. Measuring that interaction reveals a sample's own handedness. But the effect is faint, and precise control has been extraordinarily difficult. Until now.

A team at EPFL's Bionanophotonic Systems Laboratory, working with Australian collaborators, engineered flat two-dimensional structures called metasurfaces, built from tiny elements called meta-atoms. The breakthrough was not in making those atoms more complex, but in orchestrating their arrangement — the interplay between each meta-atom's shape and the symmetry of the overall lattice creates the control. Elegant simplicity outperforming brute-force complexity.

To demonstrate the technology, the team encoded two images on a single chip made from germanium and calcium difluoride. Unpolarized light reveals a cockatoo, written into the size of the meta-atoms themselves. Circularly polarized light reveals a second image — the Matterhorn — hidden in the orientation of those same atoms. Two images, one surface, invisible until the right light arrives. The researchers call this a dual-layer watermark, with immediate applications in anticounterfeiting and security.

The implications reach further still. Quantum technologies that rely on polarized light could gain new computational possibilities. Most consequentially, the technology could detect drug composition and purity from tiny samples — because nature is built on chirality, and the difference between a medicine and a poison often comes down to which way a molecule spirals. This flat chip, sitting at the intersection of optical physics and molecular biology, may soon help ensure that the right-handed molecule reaches the patient, and never the wrong one.

A left-handed glove will never fit a right hand. The mismatch is absolute—the two are mirror images that cannot be forced into alignment. This principle of handedness, which scientists call chirality, governs far more than clothing. It shapes the structure of DNA, determines whether a sugar molecule can nourish a body or pass through it unused, and decides whether a pharmaceutical compound will heal or harm. Most naturally occurring DNA and sugars spiral one way; most amino acids spiral the other. Flip the handedness of a drug molecule, and it may become inert or toxic. The stakes are high, and the ability to detect and control chirality has long been a frontier of molecular science.

Light itself can be handed. When a beam of light becomes circularly polarized, its electric field twists through space like a corkscrew—either left-handed or right-handed. Because chiral molecules interact differently with these two types of twisted light, researchers can shine polarized light onto a sample and measure how much of each twist gets absorbed, reflected, or delayed. The result reveals the sample's own handedness. But this interaction is faint, making precise control of the effect extraordinarily difficult. Until now.

A team at EPFL's Bionanophotonic Systems Laboratory, working with collaborators in Australia, has engineered artificial optical structures called metasurfaces—flat, two-dimensional lattices built from tiny elements called meta-atoms. By varying how these meta-atoms are oriented within the lattice, the researchers can tune how the metasurface responds to polarized light. The breakthrough lies not in making the meta-atoms themselves more complex, but in orchestrating their arrangement. As Hatice Altug, who leads the lab, explains it: the interplay between the shape of each meta-atom and the symmetry of the overall lattice creates the control. It is elegant simplicity outperforming brute-force complexity. The work was published in Nature Communications.

To demonstrate what this means in practice, the team built a metasurface from germanium and calcium difluoride, with meta-atoms arranged in a gradient—their orientations shifting continuously across the chip. They then encoded two separate images on the same surface. The first image, a cockatoo, was written into the size of the meta-atoms themselves, which act as pixels. Shine unpolarized light on the chip, and the cockatoo appears. The second image, the Matterhorn, was encoded in the orientation of those same meta-atoms. Only when the chip is exposed to circularly polarized light does the mountain reveal itself. Two images, one surface, invisible to the naked eye until the right light illuminates it. The researchers call this a dual-layer watermark, and it opens immediate doors to anticounterfeiting, camouflage, and security applications where hidden information must remain undetectable until authenticated.

Beyond encryption, the implications branch in multiple directions. Quantum technologies often rely on polarized light to perform calculations; the ability to map chiral responses across large surfaces could unlock new computational possibilities. But perhaps the most consequential application lies in biosensing and pharmaceutical safety. Felix Richter, a researcher in the lab, frames it plainly: chiral metastructures like theirs could detect drug composition and purity from tiny samples. Nature is built on chirality. The difference between a medicine and a poison often comes down to which way a molecule spirals. A technology that can reliably distinguish left-handed from right-handed molecules at scale could transform how drugs are verified before they reach patients. The flat chip, no thicker than a wafer, sits at the intersection of optical physics and molecular biology—a place where the shape of light and the shape of matter finally speak the same language.

Our 'chiral design toolkit' is elegantly simple, and yet more powerful than previous approaches, which tried to control light through very complex meta-atom geometries. Instead, we leverage the interplay between the shape of the meta-atom and the symmetry of the metasurface lattice.
— Hatice Altug, Bionanophotonics Lab head
We can use chiral metastructures like ours to sense, for example, drug composition or purity from small-volume samples. Nature is chiral, and the ability to distinguish between left- and right-handed molecules is essential, as it could make the difference between a medicine and a toxin.
— Felix Richter, Bionanophotonic Systems Lab researcher
Quer a matéria completa? Leia o original em ScienceDaily ↗
Fale Conosco FAQ